AMD Showcases Growing Momentum for AMD Powered AI Solutions from the Data Center to PCs
06 déc. 2023 15h00 HE
|
Advanced Micro Devices, Inc.
— Microsoft, Dell Technologies, HPE, Lenovo, Meta, Oracle, Supermicro and others adopt new AMD Instinct MI300X and MI300A data center AI accelerators for training and inference solutions — — AMD also...
RetinalGeniX Technologies Inc. Appoints Dessy Boneva, MD, FACS to the Board of Directors
04 déc. 2023 14h45 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. APPOINTS
DESSY BONEVA, MD, FACS TO THE BOARD OF DIRECTORS Dr. Boneva is an experienced surgeon skilled in trauma, surgical
RetinalGeniX Technologies Inc. Announces Hiring of Interim CFO
01 déc. 2023 12h32 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC. ANNOUNCES HIRING OF INTERIM CFO
Virender Ahluwalia will serve as Interim Chief Financial Officer
Point sur la procédure de redressement judiciaire : dépôt d’une offre de reprise auprès des Administrateurs Judiciaires
20 nov. 2023 11h45 HE
|
Pixium Vision
Point sur la procédure de redressement judiciaire : dépôt d’une offre de reprise auprès des Administrateurs Judiciaires Paris, France, 20 novembre 2023 - 17h45 CET - Pixium Vision SA (Euronext...
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators
20 nov. 2023 11h45 HE
|
Pixium Vision
Update on the receivership proceedings: submission of a takeover offer to the court-appointed administrators Paris, France, November 20, 2023 – 5:45 pm (CET) – Pixium Vision SA (Euronext Growth...
Latest Top500 List Highlights Several World's Fastest and Most Efficient Supercomputers Powered by AMD
14 nov. 2023 09h00 HE
|
Advanced Micro Devices, Inc.
SANTA CLARA, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Today, AMD (NASDAQ: AMD) showcased its continued leadership in high performance computing (HPC) at Supercomputing 23. AMD EPYC™ processors and...
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère
14 nov. 2023 01h00 HE
|
Pixium Vision
Pixium Vision annonce les résultats de l'essai à 48 mois sur la DMLA atrophique sévère L'étude vient confirmer les résultats à 36 mois : l’utilisation de la prothèse sous-rétinienne est possible,...
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
14 nov. 2023 01h00 HE
|
Pixium Vision
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD Study confirms subretinal prothesis feasible and well-tolerated with no reduction of natural peripheral vision, confirming...
RetinalGeniX™ Technologies Inc. Announces the Submission of Two Provisional Patent Applications For Investigational Therapeutic Drugs
09 nov. 2023 12h58 HE
|
RetinalGeniX Technologies, Inc.
RetinalGeniX Announces Therapeutic Solutions Being Developed for Dry Age-Related Macular Degeneration
and Alzheimer’s Syndrome.
RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam™ Image Visualization Device
08 nov. 2023 05h45 HE
|
RetinalGeniX Technologies, Inc.
RETINALGENIX TECHNOLOGIES INC and AVANIA CRO CONTRACT to GUIDE the DEVELOPMENT of TWO DRUG THERAPIES and the RETINALCAM™ IMAGE VISUALIZATION DEVICE